HEALTH

New KIND bar honored at Expo East natural products show

BY Michael Johnsen

NEW YORK KIND Plus was awarded “best new food item” at the Natural Products Expo East held last weekend in Boston, PeaceWorks Holdings announced Thursday.

“Considering how many products were under consideration, we’re both thrilled and humbled,” stated Daniel Lubetzky, chief executive officer of PeaceWorks Holdings, the makers of KIND Fruit + Nut Bars.  “It’s an incredible honor to have industry leaders single out a KIND Snack as the best new food product at a show as large as Expo East.”

The contest was sponsored and officiated by the Natural Products Association and The Natural Foods Merchandiser magazine.

KIND Plus brings enhanced nutrition to the KIND bars by adding such targeted supplements as calcium, antioxidants, protein and Omega-3. New flavors include cranberry and almond, almond and cashew and mango macademia.

Since the start of 2008, KIND has expanded its sales locations by more than 5,000 doors in the United States, bringing the total number of retail locations to more than 20,000 stores nationwide. KIND is presently sold in nearly every major retail and grocery chain in the United States including 7-11, Albertsons, A&P, Duane Reade, GNC, Kroger, Meijer, Publix, Safeway, Shaw’s, Trader Joe’s, Wal-Mart, Whole Foods, Wild Oats and Vitamin Shoppe.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

ASCP launches chronic constipation education initiative

BY Michael Johnsen

ALEXANDRIA, Va. The American Society of Consultant Pharmacists on Thursday launched a comprehensive continuing medical education initiative for physicians, nurses, pharmacists and other health-care providers about chronic constipation.

Known as E-IMPACCT, Elderly IMProvements and Advances in Chronic Constipation Treatment, the program presents educational activities on evaluating and managing CC, and offers a range of tools to help clinicians in everyday practice.

 “Because of the cascade of complex health issues that can be triggered by chronic constipation, clinicians have expressed their need for targeted education about CC,” stated ASCP executive director and chief executive officer John Feather. “Clinicians need to identify, recognize and differentiate CC and have a clear understanding of the pros and cons of each of the treatments and medications, the side effects and administration and efficacy data.”

“For all clinicians, the management strategies for treating chronic constipation in the elderly should include a combination of patient and caregiver education and communication, dietary modifications, and treatment options,” commented ASCP director of professional and educational affairs Trish D’Antonio Mazzuca. “Educational outcomes from E-IMPACCT will measure changes in clinician knowledge and behavior and improvements in patient care.”

E-IMPACCT provides outcomes-based knowledge through an ongoing, thorough awareness campaign with educational components that will roll out over a 12-month period. Through this initiative, participants are presented with new information and certified continuing education activities, patient cases and guidelines designed to help clinicians better manage CC and improve outcomes in today’s seniors.

Chronic constipation is the most common digestive complaint in the general population. In seniors, roughly 26 percent of men and 34 percent of women complain of constipation. Americans spend approximately $800 million per year on over-the-counter laxatives, the society reported.

The ASCP E-IMPACCT initiative is supported by an educational grant from Sucampo Pharmaceuticals and Takeda Pharmaceuticals North America.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

GlaxoSmithKline wins recommendation to sell Alli in Europe

BY Michael Johnsen

LONDON GlaxoSmithKline won a recommendation from European regulators Thursday that it be allowed to sell its weight loss drug Alli over-the-counter in Europe.

The European Medicines Agency said it had recommended the switch from prescription-only to nonprescription for a 60-milligram dose of alli, the same dose approved for sale OTC in the United States. The European Commission now needs to rubber-stamp the recommendation.

The European Medicines Agency said it had recommended the switch from prescription-only to nonprescription for a 60-milligram dose of alli, the same dose approved for sale OTC in the United States. The European Commission now needs to rubber-stamp the recommendation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?